CGT4255 is an EGFR Sparing, Pan-Mutant HER2 Clinical Development Candidate with Potential Best-In-Class Brain Penetration

AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

File size: 966.27 KB
Created: April 2025
Updated: April 2025
Hits: 55
Download Preview
Scroll to Top
Scroll to Top